Illumina wins case against U.S. FTC on Grail purchase – WSJ

09/01/2022

Less than a minute

2022.09.01 19:53

Illumina wins case against U.S. FTC on Grail purchase - WSJ
FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo

(Reuters) – A judge has ruled in favor of Illumina Inc (NASDAQ:ILMN) in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission’s efforts to unwind the multi-billion-dollar deal, the Wall Street Journal reported on Thursday, citing people familiar with the matter.

The FTC had sought to stop Illumina’s $7.1 billion proposed acquisition of cancer detection test maker Grail, alleging it would harm innovation and boost prices.

Illumina and Grail did not immediately respond to Reuters requests for comment.

Source

09/01/2022

Less than a minute